Biblio Discovery — Demo Discovery Service

15 results for "Emily MacLean"

Showing 1–15 · 0.59 seconds · RSS

  1. Journal Article Full text

    Biomarkers for diagnosis of childhood tuberculosis: A systematic review.

    Toyin Omotayo Togun; Emily MacLean; Beate Kampmann et al.

    PLoS ONE, Vol. 13 No. 9 · 2018 · English · DOAJ Scopus

    IntroductionAs studies of biomarkers of tuberculosis (TB) disease provide hope for a simple, point-of-care test, we aimed to synthesize evidence on biomarkers for diagnosis of TB in children and compare their accuracy to published target product profiles (TPP).MethodsWe conducted a systematic…

    Also available at: PLOS

  2. Journal Article

    A tuberculosis biomarker database: the key to novel TB diagnostics

    Seda Yerlikaya; Tobias Broger; Emily MacLean et al.

    International Journal of Infectious Diseases, Vol. 56 No. C · 2017 · English · DOAJ Scopus

    New diagnostic innovations for tuberculosis (TB), including point-of-care solutions, are critical to reach the goals of the End TB Strategy. However, despite decades of research, numerous reports on new biomarker candidates, and significant investment, no well-performing, simple and rapid TB…

  3. Journal Article Full text

    Sandfly Fever Sicilian Virus-Leishmania major co-infection modulates innate inflammatory response favoring myeloid cell infections and skin hyperinflammation.

    Ellen Heirwegh; Emily MacLean; Jinlei He et al.

    PLoS Neglected Tropical Diseases, Vol. 15 No. 7 · 2021 · English · DOAJ Scopus

    BackgroundThe leishmaniases are a group of sandfly-transmitted diseases caused by species of the protozoan parasite, Leishmania. With an annual incidence of 1 million cases, 1 billion people living in Leishmania-endemic regions, and nearly 30,000 deaths each year, leishmaniasis is a major global…

    Also available at: PLOS

  4. Journal Article Full text

    Activation of Th2 cells downregulates CRTh2 through an NFAT1 mediated mechanism.

    Emily MacLean Scott; Lauren A Solomon; Courtney Davidson et al.

    PLoS ONE, Vol. 13 No. 7 · 2018 · English · DOAJ Scopus

    CRTh2 (encoded by PTGDR2) is a G-protein coupled receptor expressed by Th2 cells as well as eosinophils, basophils and innate lymphoid cells (ILC)2s. Activation of CRTh2, by its ligand prostaglandin (PG)D2, mediates production of type 2 cytokines (IL-4, IL-5 and IL-13), chemotaxis and inhibition of…

    Also available at: PLOS

  5. Journal Article Full text

    Most common reasons for primary care visits in low- and middle-income countries: A systematic review

    Jacob Bigio; Emily MacLean; Nathaly Aguilera Vasquez et al.

    PLOS Global Public Health, Vol. 2 No. 5 · 2022 · English · PLOS Scopus

    With the Covid-19 pandemic and the introduction of the WHO’s Essential Diagnostics List (EDL), increasing global attention is focused on the crucial role of diagnostics in achieving universal health coverage. To create national EDLs and to aid health system planning, it is vital to understand the…

    Also available at: DOAJ, DOAJ

  6. Journal Article Full text

    Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review

    Jacob Bigio; Mikashmi Kohli; Joel Shyam Klinton et al.

    PLOS ONE, Vol. 16 No. 5 · 2021 · English · PLOS Scopus

    The advent of affordable, portable ultrasound devices has led to increasing interest in the use of point-of-care ultrasound (POCUS) for the detection of pulmonary TB (PTB). We undertook a systematic review of the diagnostic accuracy of POCUS for PTB. Five databases were searched for articles…

    Also available at: DOAJ

  7. Journal Article

    Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers [version 1; peer review: 2 approved]

    Diane N. Singhroy; Emily MacLean; Mikashmi Kohli et al.

    Gates Open Research, Vol. 4 · 2020 · English · DOAJ Scopus

    Background: Since 2015, the World Health Organization (WHO) has recommended a commercially available lateral-flow urine LAM test (Alere-LAM) to assist in the diagnosis of tuberculosis (TB) in severely ill people living with HIV (PLHIV). The test can rapidly detect TB in severely ill PLHIV and can…

  8. Journal Article

    Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers [version 2; peer review: 2 approved]

    Diane N. Singhroy; Emily MacLean; Mikashmi Kohli et al.

    Gates Open Research, Vol. 4 · 2020 · English · DOAJ Scopus

    Background: Since 2015, the World Health Organization (WHO) has recommended a commercially available lateral-flow urine LAM test (Alere-LAM) to assist in the diagnosis of tuberculosis (TB) in severely ill people living with HIV (PLHIV). The test can rapidly detect TB in severely ill PLHIV and can…